Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 621: What is the antidote for poisoning due to Amanita muscaria?

A. Physostigmine
B. Amyl nitrite
C. Methylene blue
D. Atropine (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Atropine** **Mechanism and Rationale:** *Amanita muscaria* (Fly Agaric) contains several toxins, most notably **muscarine**. Muscarine acts as a potent agonist at peripheral muscarinic acetylcholine receptors. Poisoning leads to a "SLUDGE" syndrome (Salivation, Lacrimation, Urination, Defecation, GI distress, and Emesis) along with bradycardia, miosis, and bronchospasm. **Atropine** is the definitive antidote because it is a competitive muscarinic antagonist. It crosses the blood-brain barrier and binds to muscarinic receptors, effectively reversing the life-threatening parasympathetic overstimulation (especially bradycardia and bronchorrhea). **Analysis of Incorrect Options:** * **A. Physostigmine:** This is an acetylcholinesterase inhibitor used to treat *Anticholinergic* toxicity (e.g., Atropa belladonna poisoning). Giving it here would worsen muscarinic toxicity. * **B. Amyl nitrite:** Used as an antidote for **Cyanide poisoning**. It works by inducing methemoglobinemia, which has a high affinity for cyanide. * **C. Methylene blue:** This is the treatment of choice for **Methemoglobinemia**. It acts as a reducing agent to convert methemoglobin (Fe³⁺) back to functional hemoglobin (Fe²⁺). **High-Yield NEET-PG Pearls:** 1. **Early vs. Late Mushroom Poisoning:** *Amanita muscaria* causes early-onset symptoms (within 2 hours) due to muscarine. In contrast, *Amanita phalloides* (Death Cap) causes late-onset symptoms (6–24 hours) due to **amatoxins**, leading to fatal hepatic necrosis. 2. **Ibotenic Acid/Muscimol:** Besides muscarine, *A. muscaria* contains these GABAergic/Glutamatergic toxins which cause CNS effects (hallucinations, "Alice in Wonderland" syndrome), but the peripheral cholinergic crisis is the primary reason for choosing Atropine. 3. **Atropine Flush:** Remember the mnemonic for atropine/anticholinergic overdose: "Red as a beet, dry as a bone, blind as a bat, mad as a hatter, and hot as a hare."

Question 622: Aplastic anemia is commonly associated with which drug?

A. Chloramphenicol (Correct Answer)
B. Cephalosporin
C. Tetracycline
D. Penicillin

Explanation: **Explanation:** **Chloramphenicol** is a broad-spectrum antibiotic that is classically associated with bone marrow suppression. It causes two distinct types of hematological toxicity: 1. **Dose-dependent anemia:** A reversible suppression of erythropoiesis. 2. **Idiosyncratic Aplastic Anemia:** A rare (1 in 20,000–40,000), unpredictable, and often fatal reaction. It is **not dose-related** and can occur even after a single dose or weeks after stopping the drug. The mechanism involves the conversion of the drug’s nitrobenzene ring into toxic metabolites that trigger genetic damage to pluripotent stem cells. **Analysis of Incorrect Options:** * **B. Cephalosporins:** These are generally bone marrow safe. Their primary hematological side effect is immune-mediated hemolytic anemia or hypoprothrombinemia (specifically Cefotetan/Cefoperazone). * **C. Tetracyclines:** These are primarily associated with GI upset, phototoxicity, and dental discoloration/bone growth inhibition in children. They do not typically cause aplastic anemia. * **D. Penicillins:** The most common adverse effect is hypersensitivity (Type I IgE-mediated reactions). While high doses can rarely cause neutropenia or hemolytic anemia, they are not a classic cause of aplastic anemia. **NEET-PG High-Yield Pearls:** * **Gray Baby Syndrome:** Another critical side effect of Chloramphenicol in neonates due to deficient **UDP-glucuronyltransferase** enzyme and poor renal excretion. * **Mechanism of Action:** Inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit** (peptidyl transferase step). * **Other drugs causing Aplastic Anemia:** Phenylbutazone, Gold salts, Carbamazepine, Benzene, and Sulphonamides.

Question 623: Which of the following drugs can cause hypokalemia?

A. Amphotericin B
B. Insulin
C. Cyclosporine (Correct Answer)
D. Carbenoxolone

Explanation: ### Explanation The question asks to identify the drug associated with **hypokalemia**. However, there is a significant clinical discrepancy in the provided key: **Cyclosporine typically causes hyperkalemia, not hypokalemia.** In the context of NEET-PG pharmacology, here is the breakdown of the electrolyte effects for each drug: **1. Cyclosporine (Option C - Marked Correct):** Cyclosporine is a calcineurin inhibitor that frequently causes **hyperkalemia**. It does this by suppressing aldosterone synthesis and reducing the activity of the Na+/K+ ATPase pump in the collecting duct. It also causes renal vasoconstriction and reduces GFR. *Note: If this was the intended answer in a specific exam source, it is likely a factual error in the question paper or refers to a rare paradoxical effect.* **2. Amphotericin B (Option A):** This is a classic cause of **hypokalemia**. It increases the permeability of the distal tubular membrane, leading to a "leak" of potassium ions. It is also associated with Type 1 Renal Tubular Acidosis (RTA) and hypomagnesemia. **3. Insulin (Option B):** Insulin causes **hypokalemia** by stimulating the Na+/K+ ATPase pump, which shifts potassium from the extracellular fluid into the intracellular compartment. This is the physiological basis for using insulin/dextrose to treat hyperkalemia. **4. Carbenoxolone (Option D):** This drug (used for peptic ulcers) has mineralocorticoid-like activity. It inhibits the enzyme 11β-HSD2, leading to an excess of cortisol acting on mineralocorticoid receptors, which causes sodium retention and **potassium wasting (hypokalemia)**. ### NEET-PG High-Yield Pearls: * **Drugs causing Hyperkalemia:** K-sparing diuretics (Spironolactone), ACE inhibitors/ARBs, NSAIDs, Cyclosporine, Tacrolimus, and Heparin. * **Drugs causing Hypokalemia:** Diuretics (Thiazides/Loop), Amphotericin B, Beta-2 agonists (Salbutamol), Insulin, and Corticosteroids. * **Amphotericin B Toxicity:** Always monitor K+ and Mg2+ levels; "Liposomal" formulations are less nephrotoxic.

Question 624: Which of the following is used in beta-blocker overdose?

A. Atropine
B. Glucagon
C. Calcium chloride
D. All of these (Correct Answer)

Explanation: **Explanation:** Beta-blocker toxicity leads to profound bradycardia, hypotension, and myocardial depression by inhibiting the $\beta_1$ receptors and decreasing intracellular cAMP levels. Management requires a multi-modal approach to restore heart rate and contractility. **Why "All of these" is correct:** * **Glucagon (Drug of Choice):** It is considered the specific antidote for beta-blocker overdose. Glucagon acts on independent G-protein coupled receptors on the myocardium, bypassing the blocked beta-receptors to activate adenylate cyclase. This increases intracellular **cAMP**, leading to positive inotropic and chronotropic effects. * **Atropine:** As an anticholinergic, it is the initial drug used to manage symptomatic bradycardia. It works by blocking vagal tone, though it is often insufficient alone in severe toxicity. * **Calcium Chloride/Gluconate:** Calcium is used to improve myocardial contractility (inotropy). It helps overcome the negative inotropic effects caused by the blockade of calcium influx usually mediated by beta-receptors. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line for Bradycardia:** Atropine. 2. **Specific Antidote:** Glucagon. 3. **Refractory Cases:** If the above fail, **High-dose Insulin Euglycemic Therapy (HIET)** is highly effective as insulin acts as a potent inotrope by improving glucose uptake by myocytes. 4. **Lipid Emulsion Therapy:** Used for toxicity caused by lipid-soluble beta-blockers (e.g., Propranolol). 5. **Membrane Stabilizing Activity (MSA):** Propranolol overdose is particularly dangerous due to sodium channel blockade, which can cause QRS widening (treated with Sodium Bicarbonate).

Question 625: Therapeutic drug monitoring is required for which of the following drugs?

A. Sulfonamides
B. Metformin
C. Cycloserine
D. Gentamycin (Correct Answer)

Explanation: **Explanation:** Therapeutic Drug Monitoring (TDM) is essential for drugs with a **narrow therapeutic index**, where the difference between the effective dose and the toxic dose is minimal, and for drugs where plasma concentration correlates better with clinical effect than dosage. **Why Gentamycin is Correct:** Gentamycin is an aminoglycoside with a narrow therapeutic window. It is associated with significant **nephrotoxicity** and **ototoxicity**. Monitoring peak levels ensures efficacy (concentration-dependent killing), while monitoring trough levels is critical to prevent accumulation and minimize toxicity. TDM is mandatory for aminoglycosides, especially in patients with renal impairment or those on prolonged therapy. **Why the Other Options are Incorrect:** * **Sulfonamides:** These are monitored based on clinical response and the appearance of adverse effects (like rashes or crystalluria) rather than plasma levels. * **Metformin:** Its efficacy is monitored by blood glucose levels and HbA1c. Plasma level monitoring does not correlate directly with its clinical management. * **Cycloserine:** While it is a second-line antitubercular drug with neurotoxic potential, it is not a standard candidate for routine TDM in general clinical practice compared to aminoglycosides. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for TDM drugs:** "**L**earn **T**he **D**rugs **Q**uickly **A**nd **P**revent **V**ery **F**atal **E**rrors" (**L**ithium, **T**ricyclic antidepressants/Theophylline, **D**igoxin, **Q**uinidine, **A**minoglycosides, **P**henytoin, **V**alproate, **F**lecanide, **E**thosuximide). * **Exceptions:** TDM is **not** required for drugs with a wide therapeutic index (e.g., Penicillin) or drugs whose effect is easily measured (e.g., Warfarin via PT/INR, Antihypertensives via BP).

Question 626: A 30-year-old male is taking methotrexate 7.5 mg once daily for arthritis and wishes to start a family. His wife takes no other medication apart from oral contraceptive pills. What advice should be given before conception?

A. The husband should stop methotrexate, and the wife should continue contraception for 3 months. (Correct Answer)
B. The husband should stop methotrexate, and the wife should continue contraception for 1 year.
C. The wife should conceive immediately, but the husband should stop methotrexate.
D. Consider adoption.

Explanation: ### Explanation **1. Why Option A is Correct:** Methotrexate (MTX) is a folic acid antagonist that interferes with DNA synthesis. In males, MTX can cause **oligospermia** and carries a theoretical risk of **chromosomal abnormalities** in sperm. Because the process of spermatogenesis (from spermatogonia to mature spermatozoa) takes approximately **74 days (roughly 3 months)**, it is clinically recommended that men discontinue MTX at least 3 months before attempting conception. This ensures that the sperm used for fertilization were not exposed to the drug during their developmental cycle. **2. Why Other Options are Incorrect:** * **Option B:** While a 1-year washout period is used for drugs with extremely long half-lives (like Leflunomide without a washout procedure), it is unnecessary for MTX, which is cleared relatively quickly. * **Option C:** Conceiving immediately poses a risk of teratogenicity or pregnancy loss due to the potential presence of damaged sperm currently in the epididymal reservoir. * **Option D:** Adoption is an extreme measure. MTX-induced effects on sperm are generally reversible upon discontinuation of the drug. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** MTX inhibits **Dihydrofolate Reductase (DHFR)**, preventing the conversion of DHF to THF. * **Teratogenicity:** MTX is a potent **Category X** teratogen. In females, it can cause "Fetal Methotrexate Syndrome" (craniofacial anomalies, limb defects, and CNS growth deficiency). * **Washout Period:** Both males and females should discontinue MTX for at least **one full ovulatory/spermatogenic cycle** (clinically standardized to **3 months/90 days**) before conception. * **Rescue Therapy:** **Leucovorin (Folinic acid)** is used to "rescue" normal cells from MTX toxicity by bypassing the inhibited DHFR enzyme.

Question 627: Individuals with alcoholic cirrhosis of the liver may develop severe hepatotoxicity after doses of acetaminophen that are not toxic to individuals with normal liver function. This increased sensitivity to acetaminophen's toxicity is due to:

A. Decrease availability of acetaldehyde dehydrogenase
B. Decreased hepatocellular stores of glutathione (Correct Answer)
C. Decreased activity of Cytochrome P450 enzymes
D. Increased liver blood flow

Explanation: ### Explanation **Correct Option: B (Decreased hepatocellular stores of glutathione)** Acetaminophen (Paracetamol) is primarily metabolized via glucuronidation and sulfation. A small fraction (approx. 5–10%) is metabolized by **Cytochrome P450 (specifically CYP2E1)** into a highly reactive, toxic intermediate called **NAPQI** (*N-acetyl-p-benzoquinone imine*) [1]. In healthy individuals, NAPQI is immediately detoxified by conjugation with **Glutathione (GSH)** [1]. However, in patients with alcoholic cirrhosis, hepatotoxicity occurs at lower doses due to two synergistic mechanisms [2]: 1. **Glutathione Depletion:** Chronic alcohol consumption and malnutrition significantly deplete hepatocellular glutathione stores, leaving the liver unable to neutralize NAPQI [1, 3]. 2. **Enzyme Induction:** Chronic alcohol induces **CYP2E1**, leading to increased production of toxic NAPQI [1, 4]. **Analysis of Incorrect Options:** * **A. Acetaldehyde dehydrogenase:** This enzyme is involved in ethanol metabolism (converting acetaldehyde to acetate). While its inhibition (e.g., by Disulfiram) causes the "disulfiram-like reaction," it does not directly mediate acetaminophen toxicity. * **C. Decreased activity of Cytochrome P450:** This is incorrect because chronic alcohol actually **induces** CYP2E1. Decreased P450 activity would theoretically *reduce* the production of toxic NAPQI, making the drug less toxic, not more. * **D. Increased liver blood flow:** Cirrhosis typically leads to portal hypertension and *decreased* effective hepatic blood flow/shunting, which does not explain the biochemical mechanism of NAPQI toxicity. --- ### NEET-PG High-Yield Pearls * **Antidote:** **N-acetylcysteine (NAC)** is the treatment of choice; it acts as a glutathione precursor and substitute [2]. * **The "Alcohol-Acetaminophen Syndrome":** Chronic drinkers are at risk even with therapeutic doses (2–4g/day) due to CYP2E1 induction and low glutathione. * **Rumack-Matthew Nomogram:** Used to predict hepatotoxicity based on plasma acetaminophen levels, but it is **not** reliable for chronic ingestion or chronic alcoholics. * **Toxic Metabolite:** Always remember **NAPQI** and its association with **CYP2E1**.

Question 628: What is the most likely medication to cause disinterest in food with protein/calorie malnutrition?

A. Selective serotonin reuptake inhibitors (SSRIs) (Correct Answer)
B. Mineral oil
C. Diuretics
D. Isoniazid (INH)

Explanation: **Explanation:** The correct answer is **Selective serotonin reuptake inhibitors (SSRIs)**. **1. Why SSRIs are correct:** SSRIs (e.g., Fluoxetine, Sertraline) increase synaptic serotonin levels. Serotonin plays a critical role in satiety signaling within the hypothalamus. High levels of serotonin, particularly via the **5-HT2C receptors**, suppress appetite (anorexiant effect). In clinical practice, especially among the elderly or depressed patients, this can lead to a significant "disinterest in food," resulting in decreased caloric intake and subsequent protein-calorie malnutrition. Fluoxetine is the SSRI most commonly associated with weight loss. **2. Analysis of Incorrect Options:** * **Mineral oil:** This is a lubricant laxative. While it does not cause anorexia, its primary nutritional complication is the **malabsorption of fat-soluble vitamins (A, D, E, K)** due to its physical presence in the gut, rather than general protein-calorie malnutrition. * **Diuretics:** These primarily cause fluid and electrolyte imbalances (e.g., hypokalemia, hyponatremia). While they don't typically cause anorexia, they may lead to dehydration or zinc deficiency (with thiazides). * **Isoniazid (INH):** The hallmark nutritional side effect of INH is **Vitamin B6 (Pyridoxine) deficiency**, leading to peripheral neuropathy and sideroblastic anemia, rather than a general suppression of appetite. **3. NEET-PG High-Yield Pearls:** * **Serotonin & Appetite:** Drugs that increase serotonin (like SSRIs or the withdrawn Fenfluramine) are potent appetite suppressants. Conversely, 5-HT2 blockers (like **Cyproheptadine**) are used as appetite stimulants. * **Elderly Caution:** In geriatric populations, SSRIs should be monitored closely as they can exacerbate "anorexia of aging" and lead to frailty. * **Weight Gain Exception:** While most SSRIs cause initial weight loss, long-term use (especially **Paroxetine**) may eventually lead to weight gain.

Question 629: Ebstein anomaly is a known teratogenic effect due to which drug?

A. Clozapine
B. Phenytoin
C. Lithium (Correct Answer)
D. Lamotrigine

Explanation: **Explanation:** **Lithium (Option C)** is the correct answer. It is a mood stabilizer used primarily for Bipolar Affective Disorder (BPAD). When taken during the first trimester of pregnancy, it is classically associated with **Ebstein’s anomaly**, a rare congenital cardiac defect characterized by the "atrialization" of the right ventricle due to the downward displacement of the tricuspid valve leaflets. While the absolute risk is lower than previously thought (approx. 1–2 per 1000 exposures), it remains a high-yield association for NEET-PG. **Analysis of Incorrect Options:** * **Clozapine (Option A):** An atypical antipsychotic. It is not associated with Ebstein’s anomaly. Its primary concerns are agranulocytosis and seizures, but it is generally considered relatively safe in pregnancy (Category B). * **Phenytoin (Option B):** An antiepileptic associated with **Fetal Hydantoin Syndrome**, which presents with craniofacial dysmorphism (cleft lip/palate), hypoplastic nails/phalanges, and growth retardation. * **Lamotrigine (Option C):** Often used as an alternative to Lithium in pregnancy for BPAD maintenance. It is considered one of the safest antiepileptics during pregnancy, with a low risk of major malformations. **High-Yield Clinical Pearls for NEET-PG:** * **Management:** If a pregnant woman must continue Lithium, fetal echocardiography is recommended at 18–20 weeks. * **Lithium Toxicity:** In neonates, Lithium can cause "Floppy Baby Syndrome" (hypotonia, cyanosis, and poor suckling). * **Other Teratogens:** * **Valproate:** Neural tube defects (highest risk among AEDs). * **Warfarin:** Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * **Isotretinoin:** Severe CNS, craniofacial, and cardiac defects (absolute contraindication).

Question 630: Which of the following congenital malformations is seen in a child whose mother was treated with oral anticoagulants during pregnancy?

A. Craniofacial malformations (Correct Answer)
B. Renal agenesis
C. Long bone defects
D. All of the above

Explanation: **Explanation:** The question refers to **Fetal Warfarin Syndrome (Warfarin Embryopathy)**. Warfarin is a low-molecular-weight oral anticoagulant that crosses the placenta and is highly teratogenic, especially when administered during the first trimester (6th–9th week of gestation). **1. Why Craniofacial Malformations is Correct:** Warfarin interferes with the synthesis of vitamin K-dependent proteins required for bone and cartilage formation (specifically osteocalcin). This leads to classic **craniofacial abnormalities**, most notably **midface hypoplasia** and a **depressed/saddled nasal bridge**. Other features include stippled epiphyses (chondrodysplasia punctata) and ophthalmic defects like optic atrophy. **2. Why Incorrect Options are Wrong:** * **Renal agenesis:** This is not a characteristic feature of Warfarin embryopathy. Renal malformations are more commonly associated with drugs like **ACE inhibitors** (which cause renal dysgenesis and oligohydramnios). * **Long bone defects:** While Warfarin causes stippling of the epiphyses and can lead to **limb hypoplasia** (shortened fingers/limbs), it does not typically cause gross "long bone defects" in the same way it affects the facial skeleton and axial cartilage. * **All of the above:** Since renal agenesis is not part of the syndrome, this option is incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Alternative:** **Heparin** (both UFH and LMWH) does not cross the placenta and is the anticoagulant of choice during pregnancy. * **Critical Period:** Exposure in the **1st trimester** causes embryopathy; exposure in the **2nd/3rd trimesters** increases the risk of fetal CNS hemorrhage and microcephaly. * **Key Buzzwords:** "Nasal hypoplasia" and "Stippled epiphyses" are the most frequently tested features of Fetal Warfarin Syndrome.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free